🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Control Subjects

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Self-initiated Perturbation-based Training in Older Adults NCT06774833NA1 site📍 Hong Kong The Hong Kong Polytechnic University · Tests: Self-initiated perturbation-based balance training, Conventional balance training A Study to Evaluate MWN109 Injection in Healthy Subjects NCT06859853Phase 11 site📍 Melbourne Shanghai Minwei Biotechnology Co., Ltd · Tests: Placebo, Subcutaneous single and mutiple dose This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects NCT07304791Phase 11 site📍 London Beam Therapeutics Inc. · Tests: BEAM-103, Placebo Comparator A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade NCT07459166Phase 21 site📍 Glendale Clear Scientific, Inc. · Tests: Naloxone Hydrochloride, Fentanyl, Sterile Saline, CS-1103 Phase 1 Single Ascending Dose Study NCT06934941Phase 11 site📍 Seoul Neuramedy Co. Ltd. · Tests: NM-101, Placebo A Study to Evaluate HB0034 in Healthy Chinese Adult Participants NCT06716151Phase 11 site📍 Jinan Shanghai Huaota Biopharmaceutical Co., Ltd. · Tests: HB0034, HB0034 matching placebo A Phase Ia Clinical Trial of HW241045 NCT07448194Phase 11 site📍 Beijing Hubei Bio-Pharmaceutical Industrial Technological Institute… · Tests: HW241045, Placebo Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. NCT07377175Phase 11 site📍 Hangzhou China National Biotec Group Company Limited · Tests: BSY001 for Injection (37.5mg), BSY001 for Injection (75 mg), BSY001 for Injection (150 mg), BSY001 for Injection (200 m… Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). NCT07165431NA1 site📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: Postbiotic + nutritional recommendations, Placebo + nutritional recommendations SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population NCT07051603Phase 11 site📍 Guangzhou Shenzhen Salubris Pharmaceuticals Co., Ltd. · Tests: SAL0140, SAL0140 placebo Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants NCT07419698Phase 11 site📍 Beijing Shanghai JMT-Bio Inc. · Tests: JMT206, Placebo Fermented Dairy Product and Bifidobacterium Diversity NCT07700381NA1 site📍 Dijon Danone Global Research & Innovation Center · Tests: 28-days consumption of Product A in 45 to 60-year-old healthy subjects, 28-days consumption of Control product in 45 to… Evaluate LAE102 in Healthy and Overweight/Obese Subjects NCT06493084Phase 11 site📍 Shanghai Laekna Limited · Tests: LAE102 intravenous administration, placebo intravenous administration, LAE102 subcutaneous administration, placebo subc… Effects of Probiotic Supplementation on Stress and Anxiety in Students NCT07470645NA1 site📍 Lublin Nordic Biotic Sp. z o.o. · Tests: Probiotics, Placebo A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults. NCT07306754Phase 11 site📍 Grayslake AbbVie · Tests: ABBV-243, Placebo, ABBV-243, Placebo Advair HFA in Healthy and HAPE Predisposed Subjects NCT06040268Phase 1, Phase 21 site📍 Aurora University of Colorado, Denver · Tests: Advair HFA, Placebo Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects NCT06635226Phase 11 site📍 Seoul IlDong Pharmaceutical Co Ltd · Tests: ID110521156, Placebo of 110521156 Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation NCT06945614Phase 11 site📍 Boston General Biophysics LLC · Tests: Xenon gas inhalation Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients NCT07051629Phase 110 sites📍 Tucson📍 DeLand📍 Tamarac Suninflam Inc · Tests: SIF001, Placebo First-in-Human Single and Multiple Dose of HL-400 NCT06997484Phase 11 site📍 Baltimore Highlightll Pharmaceutical (USA) LLC · Tests: HL-400, Placebo VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population NCT07254481Phase 12 sites📍 Hangzhou📍 Shanghai Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Tests: VB19055, VB19055 placebo A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A NCT07787091Phase 1, Phase 21 site📍 Singapore Arditus Pte Ltd · Tests: ARD001, Placebo First-into-human Study of NS-136 in Healthy Subjects NCT06345703Phase 12 sites📍 Adelaide📍 Chengdu NeuShen Therapeutics · Tests: Placebo, NS-136 tablet Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366Phase 31 site📍 Liuzhou Shanghai Bovax Biotechnology Co., Ltd. · Tests: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARD… A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1 NCT07015437Phase 22 sites📍 Cincinnati📍 Norfolk Cerus Corporation · Tests: INTERCEPT Blood System for RBCs, Infusion of autologous radiolabeled RBCs Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects NCT07691957NA1 site📍 Pisa Azienda Ospedaliero, Universitaria Pisana · Tests: Microneurography, Intraneural Microstimulation Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D NCT06829563Phase 11 site📍 Adelaide Rezubio Pharmaceuticals Co., Ltd. · Tests: RZ-629, Placebo, Fasted, Fed An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Application on the Skin of Healthy Chinese Subjects NCT07673458Phase 11 site📍 Langfang Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Tests: PA032, Vehicle Ointment A Clinical Study of HRS-5765 in Healthy Participants NCT07551167Phase 11 site📍 Beijing Chengdu Suncadia Medicine Co., Ltd. · Tests: HRS-5765 Tablet, HRS-5765 Tablet Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy